NCT01873326: Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 92 taking part
- Started
- Jun 2013
- Primary completion
- Jun 2027
- Arms
- Paclitaxel, Ifosfamide and Cisplatin (TIP)
- Results
- None posted
- 10 Jun 2013: Trial registered